DE60134336D1 - Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen - Google Patents

Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen

Info

Publication number
DE60134336D1
DE60134336D1 DE60134336T DE60134336T DE60134336D1 DE 60134336 D1 DE60134336 D1 DE 60134336D1 DE 60134336 T DE60134336 T DE 60134336T DE 60134336 T DE60134336 T DE 60134336T DE 60134336 D1 DE60134336 D1 DE 60134336D1
Authority
DE
Germany
Prior art keywords
ltrpc7
methods
calcium
coducing
humane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134336T
Other languages
English (en)
Inventor
Reinhold Penner
Andrea Fleig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens Medical Center
Original Assignee
Queens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens Medical Center filed Critical Queens Medical Center
Application granted granted Critical
Publication of DE60134336D1 publication Critical patent/DE60134336D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE60134336T 2000-11-13 2001-11-13 Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen Expired - Lifetime DE60134336D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24823500P 2000-11-13 2000-11-13
US25446800P 2000-12-08 2000-12-08
PCT/US2001/047784 WO2002059307A2 (en) 2000-11-13 2001-11-13 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof

Publications (1)

Publication Number Publication Date
DE60134336D1 true DE60134336D1 (de) 2008-07-17

Family

ID=26939221

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134336T Expired - Lifetime DE60134336D1 (de) 2000-11-13 2001-11-13 Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen

Country Status (8)

Country Link
US (1) US8580525B2 (de)
EP (1) EP1337635B1 (de)
JP (1) JP4393065B2 (de)
AT (1) ATE397663T1 (de)
AU (1) AU2002253807B2 (de)
CA (1) CA2428698C (de)
DE (1) DE60134336D1 (de)
WO (1) WO2002059307A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1337635B1 (de) * 2000-11-13 2008-06-04 The Queen's Medical Center Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen
DK1599732T3 (da) * 2003-03-05 2007-07-16 Metabolex Inc Fremgangsmåde og præparater til behandling af diagnosticering af diabetes og dermed beslægtede sygdomme som involverer beta-TRP
US20070083941A1 (en) * 2005-10-06 2007-04-12 Wyeth Rat TRPM7 polynucleotide and encoded protein
US11215606B2 (en) 2016-12-02 2022-01-04 Sophion Bioscience A/S Seal enhancer
WO2018100206A1 (en) * 2016-12-02 2018-06-07 Sophion Bioscience A/S Seal enhancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4476491B2 (ja) 1998-11-12 2010-06-09 栄研化学株式会社 新規膜貫通蛋白質をコードする遺伝子
WO2000040614A2 (en) * 1998-12-30 2000-07-13 Beth Israel Deaconess Medical Center, Inc. Characterization of the soc/crac calcium channel protein family
ATE342977T1 (de) 1999-04-26 2006-11-15 Beth Israel Hospital Nukleinsäure, die für polypeptide kodieren die eine mutt-domäne enthalten
AU2001280969A1 (en) * 2000-07-31 2002-02-13 Millennium Pharmaceuticals, Inc. 18610, a human transient receptor and uses thereof
US20040010118A1 (en) * 2000-08-16 2004-01-15 Zerhusen Bryan D. Novel proteins and nucleic acids encoding same
EP1337635B1 (de) * 2000-11-13 2008-06-04 The Queen's Medical Center Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen

Also Published As

Publication number Publication date
JP4393065B2 (ja) 2010-01-06
US20090098546A1 (en) 2009-04-16
CA2428698A1 (en) 2002-08-01
AU2002253807B2 (en) 2007-10-18
EP1337635A2 (de) 2003-08-27
WO2002059307A2 (en) 2002-08-01
EP1337635B1 (de) 2008-06-04
US8580525B2 (en) 2013-11-12
ATE397663T1 (de) 2008-06-15
JP2004535549A (ja) 2004-11-25
WO2002059307A3 (en) 2003-06-05
CA2428698C (en) 2012-08-21

Similar Documents

Publication Publication Date Title
BRPI0516463A (pt) cánula escalonada e conjunto de cánula
DE59810922D1 (de) 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester-transfer-proteins (ctep)
WO2005042029A3 (en) Psma formulations and uses thereof
BR0211612A (pt) Cristais que incluem um sal de ácido málico de n-[2-(dietilamino)etil]-5-[(5-flúor2-oxo-3h-indol-3-ilide no)metil]-2,4-dimetil-1h-pirrol-3-carboxamida, processos para a sua preparação e suas composições
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DE69934242D1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
DE59609235D1 (de) Verwendung von aerogelen in der landwirtschaft
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
EE05477B1 (et) Nahale aplitseeritavad vedelpreparaadid parasiitputukate t?rjumiseks loomadel
ATE273956T1 (de) Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten
SV2002000776A (es) Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv
WO2000004865A3 (en) Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
ATE296809T1 (de) 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
DE60134336D1 (de) Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
ATE291621T1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO2002038608A3 (en) Methods of screening for ltrpc2 modulators
ATE417926T1 (de) Zusammensetzungen zur modulierung der länge von telomeren
DE60210970D1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
ATE346924T1 (de) P-glycoproteine und ihre verwendungen
DE59809344D1 (de) Disubstituierte biphenyloxazoline
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition